Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Ischemic preconditioning increases myocardial O-GlcNAc glycosylation.

Vibjerg Jensen R, Johnsen J, Buus Kristiansen S, Zachara NE, Bøtker HE.

Scand Cardiovasc J. 2013 Jun;47(3):168-74. doi: 10.3109/14017431.2012.756984. Epub 2013 Jan 10.

PMID:
23301939
3.

Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.

Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.

Cardiovasc Drugs Ther. 2006 Feb;20(1):13-25.

PMID:
16552474
4.

Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.

Vessey DA, Li L, Honbo N, Karliner JS.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1429-35. doi: 10.1152/ajpheart.00358.2009. Epub 2009 Jul 31.

5.

Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.

Champattanachai V, Marchase RB, Chatham JC.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C178-87. Epub 2006 Aug 9.

6.

Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart.

Charan K, Goyal A, Gupta JK, Yadav HN.

J Surg Res. 2016 Apr;201(2):272-8. doi: 10.1016/j.jss.2015.10.045. Epub 2015 Nov 6.

PMID:
27020807
7.

Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.

Liu J, Pang Y, Chang T, Bounelis P, Chatham JC, Marchase RB.

J Mol Cell Cardiol. 2006 Feb;40(2):303-12. Epub 2005 Dec 9.

PMID:
16337959
8.

Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.

Li R, Wong GT, Wong TM, Zhang Y, Xia Z, Irwin MG.

Anesth Analg. 2009 Jan;108(1):23-9. doi: 10.1213/ane.0b013e3181884ba6.

PMID:
19095826
9.

Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.

Kocsis GF, Pipis J, Fekete V, Kovács-Simon A, Odendaal L, Molnár E, Giricz Z, Janáky T, van Rooyen J, Csont T, Ferdinandy P.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2406-9. doi: 10.1152/ajpheart.00862.2007. Epub 2008 Mar 21.

11.

Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.

Støttrup NB, Løfgren B, Birkler RD, Nielsen JM, Wang L, Caldarone CA, Kristiansen SB, Contractor H, Johannsen M, Bøtker HE, Nielsen TT.

Cardiovasc Res. 2010 Nov 1;88(2):257-66. doi: 10.1093/cvr/cvq205. Epub 2010 Jun 18.

PMID:
20562422
12.

eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.

Talukder MA, Yang F, Shimokawa H, Zweier JL.

Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H437-45. doi: 10.1152/ajpheart.00384.2010. Epub 2010 Jun 4.

13.

Targeted deletion of regulatory T cells attenuates the protective effects of myocardial ischemic preconditioning in rats.

Ke D, Fang J, Fan L, Chen L.

Scand Cardiovasc J. 2015 Feb;49(1):64-71. doi: 10.3109/14017431.2015.1005661. Epub 2015 Feb 12.

PMID:
25580940
14.

Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.

Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH.

J Cardiovasc Pharmacol. 2007 Apr;49(4):214-20.

PMID:
17438406
15.

Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.

Balakumar P, Singh H, Reddy K, Anand-Srivastava MB.

J Cardiovasc Pharmacol. 2009 Sep;54(3):204-12. doi: 10.1097/FJC.0b013e3181b04cc5.

PMID:
19568176
16.

Inhibition of KV7 Channels Protects the Rat Heart against Myocardial Ischemia and Reperfusion Injury.

Hedegaard ER, Johnsen J, Povlsen JA, Jespersen NR, Shanmuganathan JA, Laursen MR, Kristiansen SB, Simonsen U, Bøtker HE.

J Pharmacol Exp Ther. 2016 Apr;357(1):94-102. doi: 10.1124/jpet.115.230409. Epub 2016 Feb 11.

17.
18.

AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury.

Ji L, Zhang X, Liu W, Huang Q, Yang W, Fu F, Ma H, Su H, Wang H, Wang J, Zhang H, Gao F.

PLoS One. 2013 Jul 26;8(7):e69910. doi: 10.1371/journal.pone.0069910. Print 2013.

19.

Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.

Laczy B, Marsh SA, Brocks CA, Wittmann I, Chatham JC.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1715-27. doi: 10.1152/ajpheart.00337.2010. Epub 2010 Sep 10.

20.

Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.

Yadav HN, Singh M, Sharma PL.

Eur J Pharmacol. 2010 Sep 15;643(1):78-83. doi: 10.1016/j.ejphar.2010.06.015. Epub 2010 Jun 20.

PMID:
20598682

Supplemental Content

Support Center